Susan Boyd
Psychiatry · Hagerstown, MDNPI 1164431516
Payments from drug & device makers
Across 94 payments — averaging $32.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$738
- Alkermes, Inc.$351
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$298
- Otsuka America Pharmaceutical, Inc.$264
- AbbVie$246
- Neurocrine Biosciences, Inc.$224
- plus $962 from 14 others
What the payments were for
- Food & beverage$2,85192%
- Education$2338%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $738 |
| Alkermes, Inc. | 6 | $351 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $298 |
| Otsuka America Pharmaceutical, Inc. | 10 | $264 |
| AbbVie(2 entities) | 29 | $246 |
| Neurocrine Biosciences, Inc. | 5 | $224 |
| Johnson & Johnson | 5 | $200 |
| Supernus Pharmaceuticals, Inc. | 4 | $150 |
| Vanda Pharmaceuticals Inc. | 3 | $141 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Eisai Inc. | 2 | $109 |
| Sunovion Pharmaceuticals Inc. | 3 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Indivior Inc. | 1 | $41 |
| Lundbeck LLC | 1 | $24 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Corium, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$458
- INGREZZA$137
- SPRAVATO$126
- VIVITROL$125
- Austedo XR$125
- Auvelity$124
- ARISTADA INITIO$115
- UZEDY$109
- VRAYLAR$100
- CAPLYTA$100
How this compares
$3,084 in reported general payments places this provider in the 85th percentile of 851 psychiatry providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 68 | $571,955 |
| Austedo XrDeutetrabenazine | 37 | $272,030 |
| AustedoDeutetrabenazine | 20 | $112,422 |
| Invega SustennaPaliperidone Palmitate | 34 | $92,357 |
| Abilify MaintenaAripiprazole | 28 | $74,701 |
| VraylarCariprazine Hcl | 46 | $67,674 |
| RexultiBrexpiprazole | 24 | $54,203 |
| LybalviOlanzapine/Samidorphan Malate | 25 | $43,057 |
| AristadaAripiprazole Lauroxil | 11 | $39,040 |
| AuvelityDextromethorphan Hbr/Bupropion | 16 | $17,735 |
| BelsomraSuvorexant | 27 | $14,114 |
| Lurasidone Hcl | 42 | $9,523 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 35 | $7,857 |
| Fluoxetine Hcl | 164 | $5,066 |
| TrintellixVortioxetine Hydrobromide | 11 | $4,967 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $224 | $571,95568 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo | $738 | $384,45257 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $264 | $128,90452 claims |
| Johnson & JohnsonInvega Sustenna | $200 | $92,35734 claims |
| Alkermes, Inc.Lybalvi, Aristada | $351 | $82,09736 claims |
| AbbVieVraylar | $246 | $67,67446 claims |
| Axsome Therapeutics, Inc.Auvelity | $124 | $17,73516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 851 psychiatry providers in Maryland.
Other psychiatry in Hagerstown
- Jamal FawazHagerstown$321K
- Eduardo EspiridionHagerstown$48K
- Elia Acevedo DiazGaithersburg$15.8M
- Akira SawaBaltimore$5.1M
- John VaethBaltimore$2.1M
- Paul RosenbergBaltimore$1.9M
- Scott AaronsonBaltimore$1.3M
- Karen AndersonBaltimore$1.1M
- Constantine LyketsosBaltimore$1.1M
- Alan JonasBaltimore$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.